High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype
- 20 December 2014
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 122 (1) , 43-51
Abstract
Chemokines are a superfamily of small heparin-binding cytokines that induce leukocytes to migrate to sites of inflammation or injury through interacting with specific transmembrane G protein-coupled receptors. Currently, attention is focused on chemokine/chemokine receptor pairs and their ability to promote tumor cell migration and angiogenesis. The chemokine receptor CXCR3 is involved in tumor metastasis and is used as a prognostic biomarker. However, its relationship with the clinicopathological features of primary glioblastoma multiforme (pGBM) and its potential prognostic value have yet to be investigated. Here, we report that high CXCR3 expression conferred poor survival in pGBM patients. Further analysis showed that CXCR3 served as an independent prognostic biomarker for pGBM patients. In addition, functional assays indicated that CXCR3 induced glioma cell invasion. Therefore, this evidence indicates CXCR3 is an independent prognostic factor for pGBM patients and promotes an invasive phenotype, which suggests a new potential biotarget for glioblastoma multiforme therapy.Keywords
This publication has 32 references indexed in Scilit:
- The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinomaBiomedicine & Pharmacotherapy, 2012
- MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10Brain Research, 2011
- Chemokine receptor CXCR3 promotes growth of gliomaCarcinogenesis, 2010
- Potential role of miRNAs and their inhibitors in glioma treatmentExpert Review of Anticancer Therapy, 2010
- Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismBritish Journal of Cancer, 2009
- The chemokine receptors CXCR4 and CXCR3 in cancerCurrent Oncology Reports, 2009
- Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodesOncogene, 2007
- Antagonism of CXCR3 Inhibits Lung Metastasis in a Murine Model of Metastatic Breast CancerCancer Research, 2006
- CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factorsJournal of Clinical Pathology, 2006
- Molecular Mechanisms of Glioma Cell Migration and InvasionJournal of Neuro-Oncology, 2004